Phio pharmaceuticals corp. (PHIO)
CashFlow / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Jun'12Mar'12
Cash flows from operating activities:
Net loss

-8,908

-7,975

-7,374

-7,240

-7,360

-7,635

-8,618

-9,231

-12,452

0

0

0

-10,223

-9,911

-9,621

-9,461

-8,800

-9,004

-8,857

-8,812

-20,925

0

0

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

67

71

76

79

81

83

84

79

70

0

0

0

77

79

86

86

87

89

88

95

99

0

0

0

0

0

Gain on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Non-cash lease expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Accretion and receipt of bond discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Non-cash stock-based compensation expense

300

434

426

401

282

155

159

241

314

0

0

0

1,535

1,687

1,756

1,766

1,846

1,875

1,870

1,842

1,979

0

0

0

0

0

Fair value of common stock warrants issued in exchange for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Acquired in-process research and development

-

-

-

-

-

-

-

-

4,696

0

0

0

228

0

0

0

-

-

-

-

12,250

0

0

0

-

-

Deferred taxes

-

-

-

-

-

-

-

-

-1,621

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of Parent Company's shares mandatorily redeemable for cash upon exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of Parent Company's common stock and common stock warrants issued in exchange for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Change in fair value of derivatives of Parent Company issued in connection with various equity financings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Loss on exchange of equity instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of Parent Company common stock issued in exchange for licensing rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Changes in operating assets and liabilities:
Prepaid expenses and other assets

113

219

66

-71

2

43

104

63

51

0

0

0

-

-

-

-

139

329

158

122

89

0

0

0

0

0

Right of use asset

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Accounts payable

259

365

194

200

39

-211

-199

-151

-608

0

0

0

878

85

342

182

122

-40

-65

-89

-253

0

0

0

0

0

Due to former parent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Accrued expenses and other liabilities

-257

-525

-1,119

-1,299

-560

-333

504

409

129

0

0

0

104

485

505

73

-793

-60

-231

311

1,028

0

0

0

0

0

Lease Liability

-102

-78

-53

-28

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-47

-61

-78

-89

-71

-86

-161

-788

-400

0

0

0

0

0

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

0

-7,317

-7,330

-7,133

-7,350

-7,758

0

0

0

-

-

-

-

-

-

Net cash used in operating activities

-8,645

-7,845

-7,861

-7,788

-7,520

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Cash flows from investing activities:
Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Purchase of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,000

0

0

0

-

-

Maturities of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Cash acquired in MirImmune Inc. acquisition

-

-

-

-

-

-

-

-

100

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for purchase of property and equipment

72

82

21

6

5

0

15

201

203

0

0

0

57

0

0

0

-

-

-

-

78

0

0

0

-

-

Proceeds from disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Cash paid for lease deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

0

-5,557

0

0

0

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-72

-82

-21

-6

-5

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Cash flows from financing activities:
Cash contributions from Parent Company, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Proceeds from issuance of Series A convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Proceeds from issuance of convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net proceeds from the issuance of common stock

-

-

-

0

-

-

-

0

-

-

-

-

-

0

0

0

-

-

-

-

15,651

0

0

0

-

-

Proceeds from the issuance of common stock upon exercise of pre-funded warrants

72

165

165

148

105

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Proceeds from the issuance of common stock in connection with the employee stock purchase plan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Net cash provided by financing activities

772

13,396

13,383

17,934

18,823

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Cash paid in lieu of fractional shares for 1:30 reverse stock split

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Repayments of capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

0

0

0

0

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

9,495

0

0

0

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and restricted cash

-

0

0

10,140

-

-2,176

-2,387

-7,599

-9,325

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-3,379

-1,095

-5,925

-2,430

-2,894

-1,717

3,324

-10,633

6,263

0

0

0

0

0

Cash paid for interest

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash received during the period for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Cash paid during the period for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Supplemental disclosure of non-cash investing and financing activities:
Series A and Series A-1 convertible preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

Fair value of Series A and Series A-1 convertible preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

209

0

0

0

-

-

-

-

-

-

-

-

-

-

Exchange of convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

Exchange of Series A convertible preferred stock into Series A-1 convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

0

-

-

Right of use asset obtained in exchange for operating lease liability

620

620

620

620

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Value of Parent Company restricted stock units and common stock issued in lieu of bonuses included in accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Value of Parent Company restricted stock units issued in lieu of cash bonuses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of Parent Company stock options modified

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Reclassification of derivative liability upon elimination of obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of Series A convertible preferred stock beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Accretion of Series A convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Conversion of notes payable into Series A convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Conversions of convertible preferred stock into common stock

-

-

-

-

-

-

-

-

-

-

-

0

-

7,114

9,671

6,896

3,882

0

0

0

-

-

-

0

-

-

Cancellation of notes receivable

-

-

-

-

-

-

-

-

150

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable assumed

-

-

-

-

-

-

-

-

5

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of securities issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of Parent Company shares mandatorily redeemable for cash upon exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Allocation of management expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Equipment and furnishings exchanged for Parent Company common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of securities issued

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Fair value of Series A and Series A-1 convertible preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

Series A and Series A-1 convertible preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

0

-

-